Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of Muscle”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04452591
What this trial is testing

Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin

Who this might be right for
Non Muscle Invasive Bladder CancerHigh-grade Ta/ T1 Papillary Disease Bladder Cancer
CG Oncology, Inc. 190
Not applicableStudy completedNCT00829920
What this trial is testing

The Effect of Treatment on Circulating Tumor Cells in Bladder Cancer Patients With Muscle-invasive or Advanced Disease

Who this might be right for
Bladder Cancer
University of Colorado, Denver 44
Testing effectiveness (Phase 2)Study completedNCT01589094
What this trial is testing

Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Memorial Sloan Kettering Cancer Center 51
Early research (Phase 1)Study completedNCT03291288
What this trial is testing

Effect of Pexidartinib on the Way the Body Processes CYP3A4 and CYP2C9 Substrates (Pharmacokinetics)

Who this might be right for
Drug Interaction Potential
Daiichi Sankyo 32
Not applicableStudy completedNCT07352761
What this trial is testing

Bilateral Uterine Artery Occlusion During Laparoscopic Myomectomy

Who this might be right for
Uterine Fibroids (Leiomyoma)MyomectomyMyomectomy; Surgical Blood Loss
Alexandria University 60
Post-approval studies (Phase 4)UnknownNCT03147586
What this trial is testing

Influence of Immune Nutrition Diet on 90-Day Outcomes in Patients Undergoing Radical Cystectomy

Who this might be right for
Bladder CancerOncologyInfection+3 more
Mansoura University 100
Not applicableStudy completedNCT06151379
What this trial is testing

Muscle Parameters and Pathological Response in Breast Cancer Patients

Who this might be right for
Neoadjuvant Chemotherapy
Acıbadem Atunizade Hospital 69
Not applicableActive Not RecruitingNCT03347162
What this trial is testing

Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer

Who this might be right for
CancerCancer of PancreasCancer of Liver+3 more
Rigshospitalet, Denmark 1,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT03155620
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Non-Hodgkin LymphomaAnn Arbor Stage IV Non-Hodgkin Lymphoma+42 more
National Cancer Institute (NCI) 1,377
Testing effectiveness (Phase 2)Ended earlyNCT02811159
What this trial is testing

An Extension Study of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids

Who this might be right for
Uterine Fibroids
Repros Therapeutics Inc. 20
Testing effectiveness (Phase 2)Study completedNCT01442662
What this trial is testing

Efficacy of Gemcitabine With Pazopanib as Second Line Treatment in Patient With Metastatic or Relapsed Uterine

Who this might be right for
Leiomyosarcoma
UNICANCER 106
Not applicableActive Not RecruitingNCT07163286
What this trial is testing

Malnutrition and Sarcopenia Screening in Chemotherapy Patients

Who this might be right for
Nutrition Aspect of CancerSarcopeniaChemotherapeutic Agent Toxicity
Çanakkale Onsekiz Mart University 200
Not applicableLooking for participantsNCT06421142
What this trial is testing

FAPI and FDG PET/MRI in Diagnosis and Therapy Prediction of Bladder Cancer

Who this might be right for
Urinary Bladder Neoplasms
First Affiliated Hospital of Fujian Medical University 80
Not applicableStudy completedNCT05868460
What this trial is testing

Laser Therapy on TMJ Disorders After Head and Neck Cancer.

Who this might be right for
Temporomandibular Joint Disorders
Cairo University 60
Not applicableStudy completedNCT03027479
What this trial is testing

Skeletal Muscle Energy Metabolism in Women With Weight Loss and Ovarian and/or Endometrial Cancer With Weight Loss

Who this might be right for
Weight LossOvarian CarcinomaEndometrial Carcinoma
University Hospital, Tours 70
Not applicableStudy completedNCT00898170
What this trial is testing

Effect of Myoma Removal on Blood Pressure and Erythropoetin Level

Who this might be right for
MyomaHypertension
Shiraz University of Medical Sciences 28
Not applicableActive Not RecruitingNCT02567669
What this trial is testing

Muscle Loss and Fatigue as a Consequence of Radiotherapy

Who this might be right for
Breast CancerFatigueSarcopenia
Essentia Health 20
Large-scale testing (Phase 3)Study completedNCT02451943
What this trial is testing

Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Eli Lilly and Company 509
Testing effectiveness (Phase 2)Looking for participantsNCT06975293
What this trial is testing

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

Who this might be right for
Solid TumorSarcomaLeiomyosarcoma+1 more
STORM Therapeutics LTD 107
Not applicableStudy completedNCT03834116
What this trial is testing

Resistance Inspiratory Muscle Training for Patients With Thoracic Malignancies

Who this might be right for
Lung Neoplasm Malignant
The Hong Kong Polytechnic University 196
Next Page